Uptake and Therapeutic Effectiveness of 125I- and 211At-Methylene Blue for Pigmented Melanoma in an Animal Model System

Cancer Research

Volumn 49, Issue 15, 1989, Pages 4332-4337

  Link, Eva M ^a   Brown, Ian ^b   Carpenter, Robert N ^b   Mitchell, Joseph S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; IODINE 125; MELANIN; METHYLENE BLUE; METHYLENE BLUE AT 211; RADIOISOTOPE; UNCLASSIFIED DRUG;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RADIOTHERAPY; CLONOGENIC ASSAY; CYTOCHEMISTRY; CYTOLOGY; MELANOMA B16; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ASTATINE; DRUG CARRIERS; IODINE RADIOISOTOPES; MELANOMA, EXPERIMENTAL; METHYLENE BLUE; MICE; MICE, INBRED C57BL; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0024313032     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Olander, K., Larsson, B., and Dencker, L. Thioamides as false melanin precursors: studies in murine melanomas. Acta Pharmacol. Toxicol., 52: 135-142,1983.
2. Mitchell, W., and Epstein, J. H. The affinity of melanin for chloroquine. J. Invest. Dermatol., 45:482-488,1965.
3. Potts, A. M. Further studies concerning the accumulation of polycyclic compounds on uveal melanin. Invest. Ophthalmol. Visual Sci., 3:400-404, 1964.
4. Potts, A. M. The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Ophthalmol. Visual Sci., 3:405-416,1964.
5. Blois, M. S. On chlorpromazine binding in vivo. J. Invest. Dermatol., 45: 475-481, 1965.
6. Link, E. M., and Rydzy, M. Endoirradiation of neoplastic tissues by administered radioisotopes. Proceedings of the Third Meeting of the Polish Biophysics Society, p. 62, 1978.
7. Link, E. M., and Lukiewicz, S. Biological effects of exo- and endoirradiation of hamster melanoma. Proceedings of the Third European Workshop on Melanin Pigmentation, p. 64, 1981.
8. Link, E. M., and Lukiewicz, S. A new radioactive drug selectively accumulating in melanoma cells. Eur. J. Nucl. Med., 7: 469-473, 1982.
9. Kassis, A. I., Harris, C. R., Adelstein, S. J., Ruth, T. J., Lambrecht, R., and Wolf, A. P. The in vitro radiobiology of astatine-211 decay. Radiat. Res., 105:27-36, 1986.
10. Charlton, D. E. The range of high LET effects from I decays. Radiat. Res., 107:163-171, 1986.
11. Brown, I., Carpenter, R. N., Link, E. M., and Mitchell, J. S. Potential diagnostic and therapeutic agents for malignant melanoma: synthesis of heavy radiohalogenated derivatives of methylene blue by electrophilic and nucleophilic methods. J. Radioanal. Nucl. Chem. Lett., 107:337-351,1986.
12. Rosdahl, I., and Rorsman, H. The size of the “melanocyte organ” in man. In: J. Bagnara, S. N. Klaus, E. Paul, and M. Schartl (eds.), Biological, Molecular and Clinical Aspects of Pigmentation, pp. 555-563. Tokyo: University of Tokyo Press, 1985.
13. Shaffer, R. N. α irradiation. Effect of astatine-211 on the anterior segment and on an epithelial cyst. Trans. Am. Ophthalmol. Soc., 50:607-627, 1952.
14. Stallard, H. B. Radiotherapy for malignant melanoma of the choroid. Br. J. Ophthalmol., 50:147-155, 1966.
15. Zygulska-Mach, H., Maciejewski, Z., Lukiewicz, S., Iwasiow, B., and Link, E. Clinical trials on chemical radiosensitization of the malignant melanoma of the choroid. Ophthalmologica (Basel), 178: 194-197, 1979.